These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 7934158

  • 1. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study.
    Bernell P, Kimby E, Hast R.
    Leukemia; 1994 Oct; 8(10):1631-9. PubMed ID: 7934158
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA, DiCarlo J, Groshek P, Kanakura Y, Berg D, Mayer RJ, Griffin JD.
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [Abstract] [Full Text] [Related]

  • 3. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R, Okamoto S, Takahashi S, Inoue T, Kikuno K, Aoki Y, Takada M, Irie S, Shimane M, Tojo A.
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia.
    Bettelheim P, Valent P, Andreeff M, Tafuri A, Haimi J, Gorischek C, Muhm M, Sillaber C, Haas O, Vieder L.
    Blood; 1991 Feb 15; 77(4):700-11. PubMed ID: 1993213
    [Abstract] [Full Text] [Related]

  • 5. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 15; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 6. Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma.
    Ho AD, Del Valle F, Haas R, Engelhard M, Hiddemann W, Rückle H, Schlimok G, Thiel E, Andreesen R, Fiedler W.
    Semin Oncol; 1990 Dec 15; 17(6 Suppl 10):14-8; discussion 18-9. PubMed ID: 2259918
    [Abstract] [Full Text] [Related]

  • 7. No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
    Hast R, Hellström-Lindberg E, Ohm L, Björkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Löfvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P.
    Leukemia; 2003 Sep 15; 17(9):1827-33. PubMed ID: 12970783
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
    Wörmann B, Hiddemann W, Frisch J, Zühlsdorf M, Rottmann R, Boeckmann A, Reuter C, Freire EA, Innig G, Schulz G.
    Behring Inst Mitt; 1991 Dec 15; (90):28-38. PubMed ID: 1801688
    [Abstract] [Full Text] [Related]

  • 9. Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts.
    Valent P, Sillaber C, Geissler K, Andreeff M, Tafuri A, Vieder L, Schulz G, Lechner K, Bettelheim P.
    Med Pediatr Oncol Suppl; 1992 Dec 15; 2():18-22. PubMed ID: 1306881
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
    Archimbaud E, Fenaux P, Reiffers J, Cordonnier C, Leblond V, Travade P, Troussard X, Tilly H, Auzanneau G, Marie JP.
    Leukemia; 1993 Mar 15; 7(3):372-7. PubMed ID: 8445942
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA.
    N Engl J Med; 1995 Jun 22; 332(25):1671-7. PubMed ID: 7760868
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
    Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W.
    Bone Marrow Transplant; 1992 Jun 22; 9(6):459-65. PubMed ID: 1352717
    [Abstract] [Full Text] [Related]

  • 13. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R, Ho AD, Del Valle F, Fischer JT, Ehrhardt R, Döhner H, Witt B, Huberts H, Kaplan E, Hunstein W.
    Semin Oncol; 1993 Dec 22; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.
    Wielenga JJ, Vellenga E, Groenewegen A, Sonneveld P, Löwenberg B.
    Leukemia; 1996 Jan 22; 10(1):43-7. PubMed ID: 8558936
    [Abstract] [Full Text] [Related]

  • 15. Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
    Fukushima T, Kawabata H, Sawaki T, Satoh T, Nakamura T, Iwao H, Nakajima A, Sakai T, Miki M, Fujita Y, Tanaka M, Kawanami T, Masaki Y, Okazaki T, Umehara H.
    Anticancer Res; 2012 Apr 22; 32(4):1347-53. PubMed ID: 22493369
    [Abstract] [Full Text] [Related]

  • 16. GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDS.
    Winer ES, Miller KB, Chan GW.
    Oncology (Williston Park); 2005 Apr 22; 19(4 Suppl 2):11-4. PubMed ID: 15934494
    [Abstract] [Full Text] [Related]

  • 17. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F, Rigolin GM, Castagnari B, Moretti S, Castoldi G.
    Haematologica; 1997 Apr 22; 82(2):239-45. PubMed ID: 9175331
    [Abstract] [Full Text] [Related]

  • 18. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
    Löwenberg B, van Putten W, Theobald M, Gmür J, Verdonck L, Sonneveld P, Fey M, Schouten H, de Greef G, Ferrant A, Kovacsovics T, Gratwohl A, Daenen S, Huijgens P, Boogaerts M, Dutch-Belgian Hemato-Oncology Cooperative Group, Swiss Group for Clinical Cancer Research.
    N Engl J Med; 2003 Aug 21; 349(8):743-52. PubMed ID: 12930926
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.
    Rossi HA, O'Donnell J, Sarcinelli F, Stewart FM, Quesenberry PJ, Becker PS.
    Leukemia; 2002 Mar 21; 16(3):310-5. PubMed ID: 11896533
    [Abstract] [Full Text] [Related]

  • 20. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
    Fleischhack G, Graf N, Hasan C, Ackermann M, Breu H, Zernikow B, Bode U.
    Klin Padiatr; 1996 Mar 21; 208(4):229-35. PubMed ID: 8926688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.